Drawing for EMPRISE

USPTO serial 79248734

EMPRISE

Reviewed by CopyMark Law Group

Reg. 5748028Status 709
Filing date
Status date
Registration date
May 14, 2019
Examiner
EISNACH, MICHAEL PATRICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EMPRISE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research in the field of diabetes, cardiovascular diseases and chronic kidney disease; Providing medical and scientific research information in the field of diabetes, cardiovascular diseases and chronic kidney diseaseSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 28, 2025C71TCANCELLED SECTION 71
Jul 26, 2019GPNXNOTIFICATION PROCESSED BY IB
Jul 8, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 8, 2019FIMPFINAL DISPOSITION PROCESSED
Jun 13, 2019GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 14, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 8, 2019CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 19, 2019CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Feb 26, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 22, 2019GPNXNOTIFICATION PROCESSED BY IB
Feb 6, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 6, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 6, 2019NPUBNOTICE OF PUBLICATION
Jan 15, 2019MAFRAPPLICATION FILING RECEIPT MAILED
Jan 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2019DOCKASSIGNED TO EXAMINER
Jan 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance